Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629)
10/2003
10/15/2003EP1351696A2 Composition for delivery of hematopoietic growth factor
10/15/2003EP1203079A4 Method for enhancing cellulose and modifying lignin biosynthesis in plants
10/15/2003EP0925077B1 Method for obtaining a purified collagen-based matrix from submucosa tissue
10/15/2003EP0876140B1 Improved kontrast agent solutions for intravenous administration
10/15/2003EP0874908B1 Nucleic acid molecules from plants encoding enzymes which participate in the starch synthesis
10/15/2003EP0706568B1 Vertebrate apoptosis gene: compositions and methods
10/15/2003CN1449448A 干细胞分化 Stem cell differentiation
10/15/2003CN1449447A Butinol I esterase
10/15/2003CN1449446A Streptococcus antigens
10/15/2003CN1449439A Cell fraction containing cells capable of differentiating into nervous system cells
10/15/2003CN1449410A Growth differentiation factor receptors, agonists and antagonists thereof, and methods of using same
10/15/2003CN1449250A Novel insecticidal toxins derived from bacillus thuringiensis insecticidal crystal proteins
10/15/2003CN1448505A Method for production of phytolaccatoxin medicinal active substance
10/15/2003CN1124348C Multi-functional hematopoietic receptor agonists
10/15/2003CN1124347C Method for obtg. 2-amino-4-methylphosphine butanoic acid gene
10/15/2003CN1124341C Monoclonal antibody of p-methyl benzedrine with specificity, hybridoma producing same and kit containing monoclonal antibody and its use
10/14/2003US6632980 Chromosomally-integrated inactive replicon derived from geminiviruses and single-stranded RNA viruses; cis-acting viral elements for replication; target gene with regulatory sequence
10/14/2003US6632935 Genome DNA of bacterial symbiont of aphids
10/14/2003US6632926 Amino acids inserted in hypervariable region; heavy chain variable domain of an antibody that binds vascular endothelial growth factor
10/14/2003US6632923 Low density lipoprotein binding proteins and their use in diagnosing and treating atherosclerosis
10/14/2003US6632920 Immunology; diagnosing cancer, nervous system, brain, sleep, psychological, and disorders
10/14/2003US6632790 Recombinant DNA produced; pathogen free; high purity
10/14/2003US6632670 Recombinant adeno-associated virus (AAV) with reduced levels of helper virus; cells which have been transfected with plasmid comprising nucleotide sequences encoding replication (rep) and capsid (cap) proteins
10/14/2003US6632668 Treatment with a protein-phosphorylation inhibitor having an indolo(2,3-a)carbazole such as staurosporine
10/14/2003US6632667 Using a antisense oligonucleotides targeted to a untranslated region or a stop codon region of a nucleic acid; use in treatment of Crohn's disease, diabetes, multiple sclerosis, rheumatoid arthritis, hepatitis, pancreatitis and asthma
10/14/2003US6632666 Normothermic, hypothermic and cryopreservation maintenance and storage of cells, tissues and organs in gel-based media
10/14/2003US6632651 Tissue maintenance system that applies rhythmic pulses of pressure
10/14/2003US6632645 Of given amino acid sequence; use in sequencing, reverse transcription, and amplification reactions
10/14/2003US6632637 Vectors and methods for recombinant protein expression
10/14/2003US6632625 Ob (obesity gene); receptors may be used in various assays, such as a transactivation assay to identify novel ligands
10/14/2003US6632620 Use of monoclonal antibodies selectively binding ecto- and endodermally-derived stem cells for diagnosis of neoplasm and /or treat pathological conditions defined by abnormal/insuf-ficient function of differentiated cells of a mature organ
10/14/2003US6632608 Methods and compositions relating to modulation of hepatocyte growth, plasma cell differentiation or T cell subset activity by modulation of XBP-1 activity
10/14/2003US6632602 Transgenic plants; use to alter levels of hexokinase protein expression in plants in order to repress/activate plant genes controlling physiology, metabolism, and cell development with emphasis on improved yields and quality of agricultural crops
10/14/2003US6632601 Immunoassays for anti-HCV antibodies
10/14/2003US6632446 Biocompatible substrates; free radical polymerization initiator; crosslinked networks of water soluble polymers; acrylated polyethylene glycol; microencapsulation
10/14/2003US6632424 Stimulate proliferation of hematopoietic stem or progenitor cells
10/14/2003US6631616 Cryopreservation system with controlled dendritic freezing front velocity
10/14/2003CA2263790C Method for immortalizing cells
10/14/2003CA2167521C Compositions and methods for producing sialyltransferases
10/09/2003WO2003083136A1 Method and kit for detecting membrane protein-protein interactions
10/09/2003WO2003083113A2 Growth regulating proteins
10/09/2003WO2003083112A1 Cell population provided with identification codes and method of screening cell population
10/09/2003WO2003083093A1 Host cells having improved cell survival properties and methods to generate such cells
10/09/2003WO2003083092A1 Dedifferentiated, programmable stem cells of monocytic origin, and their production and use
10/09/2003WO2003083091A1 Dedifferentiated, programmable stem cells having a monocytic origin and the production and use thereof
10/09/2003WO2003083090A1 In vitro culture of amoebocytes from tachypleus gigas in leibovitz culture medium
10/09/2003WO2003083089A2 Tolerogenic antigen-presenting cells
10/09/2003WO2003083088A2 Stem cell therapy
10/09/2003WO2003083080A2 Mixed- cell gene therapy
10/09/2003WO2003083075A2 Retrovirus-based genomic screening
10/09/2003WO2003083071A2 Diabetes-related immunoglobulin derived proteins, compositions, methods and uses
10/09/2003WO2003083070A2 Endothelial cells derived from human embryonic stem cells
10/09/2003WO2003083069A2 Activation of tumor-reactive lymphocytes via antibodies or genes recognizing cd3 or 4-1bb
10/09/2003WO2003083066A2 Methods for increasing polypeptide production
10/09/2003WO2003083065A2 Improved methods for achieving expression from alphavirus vectors
10/09/2003WO2003083064A2 Chimeric pancreas
10/09/2003WO2003083057A2 Adipocytes and uses thereof
10/09/2003WO2003083050A2 Human deubiquitinating protease gene on chromosome 7 and its murine ortholog
10/09/2003WO2003083045A2 Lambda integrase mediated recombination in plants
10/09/2003WO2003083044A2 Tissue analogs for in vitro testing and method of use therefor
10/09/2003WO2003083039A2 Therapeutic polypeptides, nucleic acids encoding same, and methods of use
10/09/2003WO2003083038A2 Disruption of the redk gene
10/09/2003WO2003082923A1 Process for crosslinking polypeptides
10/09/2003WO2003082919A2 Ox40r binding agents
10/09/2003WO2003082328A1 Use of discoidin domain receptor 1 (ddr1) and agents that affect the ddr1/collagen pathway
10/09/2003WO2003082305A1 Drug containing human placenta-origin mesenchymal cells and process for producing vegf using the cells
10/09/2003WO2003082201A2 Collagen biofabric and methods of preparation and use therefor
10/09/2003WO2003082200A2 Potent oncolytic herpes simplex virus for cancer therapy
10/09/2003WO2003082189A2 Method for producing pseudo islets
10/09/2003WO2003082145A2 Fabrication of vascularized tissue using microfabricated two-dimensional molds
10/09/2003WO2003082006A2 Methods and compositions for preventing obesity and obesity related disorders
10/09/2003WO2003081997A1 CALPAIN LARGE SUBUNIT (n-CL4) CYSTEINE PROTEASE GENE DISRUPTIONS, AND COMPOSITIONS AND METHODS RELATED THERETO
10/09/2003WO2003081993A2 Transgenic aves producing human polyclonal antibodies
10/09/2003WO2003055990A3 Method for culturing and expansion of mammalian undifferentiated epidermal keratinocytes exhibiting stem cell characteristics
10/09/2003WO2003051111A3 Cryopreservation of biological materials using pre-chilled protectant
10/09/2003WO2003040686A3 Dosing and administration of therapeutic micro-organs in living subjects and devices and methods for same
10/09/2003WO2003040300A3 Transportable contractile nerve-muscle co-culture
10/09/2003WO2003040170A3 Antibodies to cd40
10/09/2003WO2003032923A3 Induction of beta cell differentiation in human cells
10/09/2003WO2003022880A3 Synthetic hcv envelope proteins and their use for vaccination
10/09/2003WO2003020928A3 Identification of eukaryotic internal ribosome entry site (ires) elements
10/09/2003WO2003020919A3 A unit and a process for carrying out high cell density fermentation
10/09/2003WO2003020904A3 Methods of generating human cd4+ th1 cells
10/09/2003WO2003014149A3 Genetically modified cyclic-nucleotide controlled ion channels and the use thereof
10/09/2003WO2003007889A3 Therapeutic agents comprising pro-apoptotic proteins
10/09/2003WO2003000878A3 Use of fkbp chaperones as expression tool
10/09/2003WO2002097075A3 Capping enzyme of flavivirus and utilization of this protein in a process to test drugs with antiviral properties
10/09/2003WO2002094842A3 Control of myogenesis by modulation of p38 map kinase activity
10/09/2003WO2002092004A3 Use of hmg fragment as anti-inflammatory agents
10/09/2003WO2002076386A3 Method of inducing proliferation of retinal stem cells
10/09/2003WO2002069947A3 Antisense oligonucleotides and trichostatin analogue histone deacetylase-4 inhibitors against cancer
10/09/2003WO2002059154A3 Neutralizing human monoclonal antibodies against hiv-1, their production and uses
10/09/2003WO2002057429A3 A method for producing a population of homozygous stem cells having a pre-selected immunophenotype and/or genotype
10/09/2003WO2002053743A3 Mammalian tribbles signaling pathways and methods and reagents related thereto
10/09/2003WO2002040676A3 Mutant allergens
10/09/2003WO2002038797A3 Modulators of bruton's tyrosine kinase, their identification and use
10/09/2003WO2002033099A3 Human kinases
10/09/2003WO2002030433A3 Use of stem cells and cd6-depleted stem cells for inducing tolerance of allogenic transplants and/or for treating leukaemia
10/09/2003WO2002020563A3 RECEPTOR IN THE EDb FIBRONECTIN DOMAIN
10/09/2003WO2002016612A3 Genes and proteins, and their uses
1 ... 1157 1158 1159 1160 1161 1162 1163 1164 1165 1166 1167 1168 1169 1170 1171 1172 1173 1174 1175 1176 1177 ... 1827